1.
Joensuu G, Joensuu T, Nupponen N, Ruutu M, Collan J, Pesonen S, et al. A phase II trial of gefitinib in patients with rising PSA following radical prostatectomy or radiotherapy. AO [Internet]. 2012 Jan. 1 [cited 2024 Nov. 9];51(1):130-3. Available from: https://medicaljournalssweden.se/actaoncologica/article/view/31514